Kiromic Biopharma, Inc. Quarterly Return On Equity in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kiromic Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q3 2024.
  • Kiromic Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was 326 %, a 13.7% decline year-over-year.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2023 was 299 %.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2022 was -528 %, a 303% decline from 2021.
  • Kiromic Biopharma, Inc. annual Return On Equity for 2021 was -131 %, a 69.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 326 -51.7 -13.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 336 -286 -45.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 322 -6.74K -95.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 299 +827 Oct 1, 2023 Dec 31, 2023
Q3 2023 378 +636 Jul 1, 2023 Sep 30, 2023
Q2 2023 622 +757 Apr 1, 2023 Jun 30, 2023
Q1 2023 7.06K +7.19K Jan 1, 2023 Mar 31, 2023
Q4 2022 -528 -397 -303% Oct 1, 2022 Dec 31, 2022
Q3 2022 -258 -139 -116% Jul 1, 2022 Sep 30, 2022
Q2 2022 -135 +96.5 +41.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -130 +242 +65.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -131 +296 +69.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -119 +710 +85.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -231 +550 +70.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -371 -27.8 -8.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -427 +184 +30.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -830 Jul 1, 2020 Sep 30, 2020
Q2 2020 -781 Apr 1, 2020 Jun 30, 2020
Q1 2020 -344 Jan 1, 2020 Mar 31, 2020
Q4 2019 -611 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.